MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
Abstract Background Acute myeloid leukemia (AML) with the t(8;21)(q22;q22) chromosomal translocation is among the most common subtypes of AML and produces the AML1-ETO (RUNX1-ETO, RUNX1-RUNX1T1) oncogenic fusion gene. AML1-ETO functions as an aberrant transcription factor which plays a key role in b...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Experimental Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40164-021-00204-7 |
id |
doaj-97aa952932a64c95aa998f264c9dbc5e |
---|---|
record_format |
Article |
spelling |
doaj-97aa952932a64c95aa998f264c9dbc5e2021-02-07T12:51:59ZengBMCExperimental Hematology & Oncology2162-36192021-02-0110111210.1186/s40164-021-00204-7MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTRDaniel T. Johnson0Amanda G. Davis1Jie-Hua Zhou2Edward D. Ball3Dong-Er Zhang4Moores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaAbstract Background Acute myeloid leukemia (AML) with the t(8;21)(q22;q22) chromosomal translocation is among the most common subtypes of AML and produces the AML1-ETO (RUNX1-ETO, RUNX1-RUNX1T1) oncogenic fusion gene. AML1-ETO functions as an aberrant transcription factor which plays a key role in blocking normal hematopoiesis. Thus, the expression of AML1-ETO is critical to t(8;21) AML leukemogenesis and maintenance. Post-transcriptional regulation of gene expression is often mediated through interactions between trans-factors and cis-elements within transcript 3′-untranslated regions (UTR). AML1-ETO uses the 3′UTR of the ETO gene, which is not normally expressed in hematopoietic cells. Therefore, the mechanisms regulating AML1-ETO expression via the 3’UTR are attractive therapeutic targets. Methods We used RNA-sequencing of t(8;21) patients and cell lines to examine the 3′UTR isoforms used by AML1-ETO transcripts. Using luciferase assay approaches, we test the relative contribution of 3′UTR cis elements to AML1-ETO expression. We further use let-7b microRNA mimics and anti-let-7b sponges for functional studies of t(8;21) AML cell lines. Results In this study, we examine the regulation of AML1-ETO via the 3’UTR. We demonstrate that AML1-ETO transcripts primarily use a 3.7 kb isoform of the ETO 3′UTR in both t(8;21) patients and cell lines. We identify a negative regulatory element within the AML1-ETO 3′UTR. We further demonstrate that the let-7b microRNA directly represses AML1-ETO through this site. Finally, we find that let-7b inhibits the proliferation of t(8;21) AML cell lines, rescues expression of AML1-ETO target genes, and promotes differentiation. Conclusions AML1-ETO is post-transcriptionally regulated by let-7b, which contributes to the leukemic phenotype of t(8;21) AML and may be important for t(8;21) leukemogenesis and maintenance.https://doi.org/10.1186/s40164-021-00204-7AML1-ETO (RUNX1-RUNX1T1)let-7miRNAt(8;21) acute myeloid leukemia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniel T. Johnson Amanda G. Davis Jie-Hua Zhou Edward D. Ball Dong-Er Zhang |
spellingShingle |
Daniel T. Johnson Amanda G. Davis Jie-Hua Zhou Edward D. Ball Dong-Er Zhang MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR Experimental Hematology & Oncology AML1-ETO (RUNX1-RUNX1T1) let-7 miRNA t(8;21) acute myeloid leukemia |
author_facet |
Daniel T. Johnson Amanda G. Davis Jie-Hua Zhou Edward D. Ball Dong-Er Zhang |
author_sort |
Daniel T. Johnson |
title |
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR |
title_short |
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR |
title_full |
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR |
title_fullStr |
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR |
title_full_unstemmed |
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR |
title_sort |
microrna let-7b downregulates aml1-eto oncogene expression in t(8;21) aml by targeting its 3′utr |
publisher |
BMC |
series |
Experimental Hematology & Oncology |
issn |
2162-3619 |
publishDate |
2021-02-01 |
description |
Abstract Background Acute myeloid leukemia (AML) with the t(8;21)(q22;q22) chromosomal translocation is among the most common subtypes of AML and produces the AML1-ETO (RUNX1-ETO, RUNX1-RUNX1T1) oncogenic fusion gene. AML1-ETO functions as an aberrant transcription factor which plays a key role in blocking normal hematopoiesis. Thus, the expression of AML1-ETO is critical to t(8;21) AML leukemogenesis and maintenance. Post-transcriptional regulation of gene expression is often mediated through interactions between trans-factors and cis-elements within transcript 3′-untranslated regions (UTR). AML1-ETO uses the 3′UTR of the ETO gene, which is not normally expressed in hematopoietic cells. Therefore, the mechanisms regulating AML1-ETO expression via the 3’UTR are attractive therapeutic targets. Methods We used RNA-sequencing of t(8;21) patients and cell lines to examine the 3′UTR isoforms used by AML1-ETO transcripts. Using luciferase assay approaches, we test the relative contribution of 3′UTR cis elements to AML1-ETO expression. We further use let-7b microRNA mimics and anti-let-7b sponges for functional studies of t(8;21) AML cell lines. Results In this study, we examine the regulation of AML1-ETO via the 3’UTR. We demonstrate that AML1-ETO transcripts primarily use a 3.7 kb isoform of the ETO 3′UTR in both t(8;21) patients and cell lines. We identify a negative regulatory element within the AML1-ETO 3′UTR. We further demonstrate that the let-7b microRNA directly represses AML1-ETO through this site. Finally, we find that let-7b inhibits the proliferation of t(8;21) AML cell lines, rescues expression of AML1-ETO target genes, and promotes differentiation. Conclusions AML1-ETO is post-transcriptionally regulated by let-7b, which contributes to the leukemic phenotype of t(8;21) AML and may be important for t(8;21) leukemogenesis and maintenance. |
topic |
AML1-ETO (RUNX1-RUNX1T1) let-7 miRNA t(8;21) acute myeloid leukemia |
url |
https://doi.org/10.1186/s40164-021-00204-7 |
work_keys_str_mv |
AT danieltjohnson micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr AT amandagdavis micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr AT jiehuazhou micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr AT edwarddball micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr AT dongerzhang micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr |
_version_ |
1724280655428190208 |